Key result
Microalbuminuria in Japanese Type 2 diabetic patients was not associated with altered platelet aggregability compared to normoalbuminuria, despite higher blood pressure and fibrinogen levels.
Why the study?
Is microalbuminuria associated with altered platelet aggregability in Japanese Type 2 diabetic patients compared to normoalbuminuria?
Case-Control (n=42)
Is microalbuminuria associated with altered platelet aggregability in Japanese Type 2 diabetic patients compared to normoalbuminuria?
Microalbuminuria in Japanese Type 2 diabetic patients is not associated with increased platelet aggregability compared to normoalbuminuric patients, despite higher blood pressure and fibrinogen levels.
Microalbuminuria does not appear linked to altered platelet aggregability in Japanese Type 2 diabetes; hypothesis-generating and should not yet change practice.
Microalbuminuria is associated with higher cardiovascular morbidity and mortality in Type 2 (non-insulin-dependent) diabetic patients. This study was designed to assess whether Type 2 diabetic patients with microalbuminuria (urinary albumin excretion rate (AER) 20-200 microgram min-1) is associated with alterations in platelet aggregability as compared with those with normal urinary albumin excretion (AER < 20 microgram min-1). Platelet aggregability was compared between 21 Japanese Type 2 diabetic patients with microalbuminuria and 21 individually pair-matched (for age, sex, body mass index, treatment, and HbA1c level) patients with normoalbuminuria. The in vitro platelet aggregation induced by 1.0 and 3.0 mumol l-1 ADP and 0.5 and 1.0 mg l-1 collagen was measured using platelet-rich plasma. No significant differences were observed between the two groups in the values for maximum percent platelet aggregation, percent aggregation at 3 min, and aggregation velocities after adding ADP or collagen. Microalbuminuric patients had significantly higher mean values for systolic (p < 0.004) and diastolic (p < 0.02) blood pressures and plasma fibrinogen level (p < 0.03) as compared with the respective mean values in normoalbuminuric patients. The results suggest that Japanese microalbuminuric Type 2 diabetic patients do not differ in the degree of platelet aggregability as compared with normoalbuminuric patients, despite an increase in certain other coronary risk factors.
No takes yet. Share an insight, caveat, or question.
Baba et al. (1993) conducted a case-control in Type 2 Diabetes (n=42). Microalbuminuria vs. Normoalbuminuria was evaluated on Platelet aggregability (maximum percent platelet aggregation, percent aggregation at 3 min, and aggregation velocities). Microalbuminuria in Japanese Type 2 diabetic patients was not associated with altered platelet aggregability compared to normoalbuminuria, despite higher blood pressure and fibrinogen levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Diabetic Medicine